Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CME Group (NQ: CME )

201.12 -0.60 (-0.30%)
Streaming Delayed Price Updated: 11:31 AM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CME Group

< Previous 1 2 3 4 5 6 7 8 9 Next >
(CME) - Analyzing CME Gr's Short Interest
Via Benzinga
Why CME GROUP INC (NASDAQ:CME) Deserves Consideration as a Quality Investment.
Is CME GROUP INC (NASDAQ:CME) a Strong Candidate for Quality Investing? 
Via Chartmill
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $15,000 Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
The Latest Analyst Ratings for CME Gr
Via Benzinga
Exploring NASDAQ:CME's quality characteristics.
Why CME GROUP INC (NASDAQ:CME) should be investigated by quality investors. 
Via Chartmill
Here's How Much You Would Have Made Owning CME Gr Stock In The Last 20 Years
Via Benzinga
Constellation Brands To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Wednesday
TD Cowen raised the price target for Constellation Brands, Inc. (NYSE: STZ) from $240 to $300. TD Cowen analyst Vivien Azer upgraded the stock from Market Perform to Outperform. Constellation Brands... 
Via Benzinga
Manchester United, Trip.com Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
A Look Into CME Gr Inc's Price Over Earnings
Via Benzinga
TJX, ON Semiconductor And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed sharply higher on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Here's How Much $100 Invested In CME Gr 20 Years Ago Would Be Worth Today
Via Benzinga
Why the quality investor may take a look at NASDAQ:CME.
CME GROUP INC (NASDAQ:CME) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
This Is What Whales Are Betting On CME Gr
Via Benzinga
How Is The Market Feeling About CME Gr?
Via Benzinga
Moody's Downgrades 10 Banks: Here's What Investors Need to Know
Moody's downgraded the banks months after the collapse of Silicon Valley Bank. 
Via The Motley Fool
Cboe Introduces New Options Contracts On Corporate Bonds
Cboe Global Markets (BATS: CBOE) is set to enhance its corporate bond index product suite by introducing new options based on the Cboe iBoxx iShares $ High Yield Corporate Bond Index futures (IBHY) and... 
Via Benzinga
P/E Ratio Insights for CME Gr
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,400 Today
Via Benzinga
6 Analysts Have This to Say About CME Gr
Via Benzinga
If You Invested $5,000 in AGNC Investment 10 Years Ago, This Is How Much You Would Have Today
The stock has delivered an ultra-high dividend yield of 14%, but has it outperformed the market? 
Via The Motley Fool
Here's How Much $100 Invested In CME Gr 20 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About CME Gr?
Via Benzinga
Price Over Earnings Overview: CME Gr
Via Benzinga
Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories
Wall Street Journal 
Via Benzinga
CME Group To Terminate 3% Of Workforce, Relocate Positions To Cloud Technology: Report
CME Group Inc. (NASDAQ: CME) reportedly plans to terminate about 100 positions, or 3% of its workforce, while reallocating some jobs. 
Via Benzinga
Is Charles Schwab Stock a Buy?
Charles Schwab's second quarter was encouraging for investors. 
Via The Motley Fool
"Rule Breaker Investing" Market Cap Game Show: A Battle of Wits
Sometimes you know the market cap, sometimes you're just guessing. 
Via The Motley Fool
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at... 
Via Benzinga
These High-Yield Dividend Stocks Are Growing at Blazing Speeds
They both had blowout quarters 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.